Pharmaceutical

Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs

Novo Nordisk's obesity drugs are driving Danish growth as well as record profits as the company becomes second-most valuable in Europe.

Sep 1, 2023 - 20:00
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Novo Nordisk's obesity drugs are driving Danish growth as well as record profits as the company becomes second-most valuable in Europe.
Read the original article

Tags:

Previous Article

Bayer looks to expand Kerendia label to include heart failure

Next Article

The changing of the guard is expected in the Crohn’s disease marketplace

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound

STAT+: FDA cracks down on websites that claim to sell c...

Feb 15, 2024

Signal: Kroger to pay up to $1.4bn to settle opioid crisis lawsuits

Signal: Kroger to pay up to $1.4bn to settle opioid cri...

Sep 11, 2023

Sudo secures additional funds to advance TYK2 inhibitors to clinic

Sudo secures additional funds to advance TYK2 inhibitor...

Feb 14, 2024